NanoViricides Inc. (NNVC)

[Puffer]

And I will add that only the ability to get such outrageous prices will support a stock price in the $100 range.

More baseless crap, nanopat is not impressed. So here is some more soundly reasoned crap --

Tamiflu sells for about $100 a dose and did nearly $3B in sales in 2009. Flucide oral, a drug that is likely to work much better, will no doubt exceed that $100 by at least 50%. (We've been told the market for flucide would approximate $3 to $7 Billion). But let's just use the low number and put a VERY conservative, in this case, 5X sales on that. That gets you pretty quickly to $15B in market cap, or about 200X the current stock price. So it should become obvious pretty quickly how baseless your statement above is as well. No outrageous pricing needed at all. All I'm doing is using current industry comps on a drug that is not all that effective.